Replies to post #105902 on Creative Medical Technology Holdings Inc (CELZ)

[uplinkjim]

The ImmCelz® cell therapy product has demonstrated efficacy in animal models of stroke, heart failure, autoimmunity, and liver failure. While the majority of companies utilize stem cell administration for therapeutic intent, ImmCelz® uses stem cells to "reprogram" patient immune cells, a process which endows the immune cells with ability to regenerate injured organs.

[BERKSHIRE AGENT]

This is Huge News. Thanks for your analysis STERVC. Looks like this is a very rare opportunity feeling like how it was in 2013 when they sold MEDISTEM and it ran PENNIES to over $2+++ a share!

[Thunderstruck]

Thank you Sterling! Great efforts!